Six Regions, One Documentation Standard
Every region page below covers the device registration route, the therapy fit and the entry strategy — with the same boundary discipline: what we document is device-side, and we say plainly what belongs to your regulatory team.
Southeast Asia
Indonesia, the Philippines and Vietnam — AKL, CMDRR and DAV device routes, an insulin base served by the A-60 and WH-RG, and GLP-1 growth served by the WH-DG configurations.
Brazil & Latin America
ANVISA registration through a BRH holder, tender-ready documentation, COFEPRIS reference routes in Mexico, and the antidumping classification question answered up front.
Middle East
Saudi SFDA and UAE MOHAP registration routes, local authorised representatives, Dubai as a re-export hub, and a needle-first entry strategy.
South Asia
India, Bangladesh and Pakistan — CDSCO MD-15 routes and ODM partnerships with regional registration holders.
Europe
CE MDR class IIb/III route planning, notified-body timing and human-factors documentation for EU submissions.
North America
The US and Canada — DMF-referenced pen pathways, 510(k) context for needles, and QMS evidence for FDA review.